Luxembourg Institute of Health (LIH)

Luxembourg Institute of Health (LIH)

Core business

The Luxembourg Institute of Health (LIH) is a public biomedical research organisation focused on precision health and invested in becoming a leading reference in Europe for the translation of scientific excellence into meaningful benefits for patients.

The LIH places the patient at the heart of all its activities, driven by a collective obligation towards society to use knowledge and technology arising from research on patient derived data to have a direct impact on people’s health. Its dedicated teams of multidisciplinary researchers strive for excellence, generating relevant knowledge linked to immune related diseases and cancer. The institute embraces collaborations, disruptive technology and process innovation as unique opportunities to improve the application of diagnostics and therapeutics with the long-term goal of preventing disease.


Products & services

LIH aims to perform research that transcends the boundaries of classical disease definition. Its translational and transversal research strategy, combined with the increasing appreciation of the role of the immune system in determining disease, has led LIH to focus on two priority areas, with inflammation and immunity as the common thread:

The objective is to understand how distinct diseases are connected by shared immune-related mechanisms and to exploit this understanding towards the development of new diagnostics, innovative therapies and effective tools for personalised medicine, therefore putting the patient at the centre of LIH’s activities.

LIH strives for international research leadership, impact and innovation. Its research seeks to produce transformative and lasting solutions to make lives healthier, safer and more resilient by maintaining its excellence in interdisciplinary fundamental and translational research.

Major HealthTech projects

LIH aims to perform patient-centric research placing patients at its heart, so as to be able to effectively generate and use knowledge and technology arising from outstanding research to have a direct and meaningful impact on people’s health. To this end, clinical studies and trials are crucial in order to develop new diagnostic and therapeutic solutions and test their efficacy directly on patients.

Close collaborations with healthcare providers and clinicians, as well as the active involvement of their patients, are the key in this context. Indeed, clinical studies depend significantly on the quality of the patient-derived biological samples and data used. Ensuring that patients contribute to such studies by providing samples and data, and that researchers have the necessary tools and expertise to effectively use such resources to generate accurate patient-derived models allowing them to investigate disease mechanisms and test drug efficacy, lie at the core of LIH’s approach.

Print this page Send by email
Luxembourg Institute of Health (LIH)


Prof. Dr. Ulf Nehrbass

Creation date




Organisation type


Trading area



Luxembourg Institute of Health
1A Rue Thomas Edison
L-1445 Strassen


Arnaud D’Agostini
Head of Marketing and Communication

Les cookies participent au bon fonctionnement de ce site internet. En utilisant ce dernier, vous acceptez l’utilisation des cookies. En savoir plus